Restoring Lysosomal Function via Ion Channel Modulation

Restoring Lysosomal Function via Ion Channel Modulation

Why Lysosomal Ion Channels Matter

With aging, the autophagy-lysosomal pathway (ALP) progressively declines, leading to impaired protein turnover, organelle damage, and the accumulation of toxic aggregates — including alpha-synuclein, Aβ, p-tau tangles, TDP-43, and lipofuscin — seen across major neurodegenerative diseases. Lysosomal ion channels such as TRPML1, TMEM175, ATP12A2, and TPC2 function as key signaling sensors that regulate calcium homeostasis, membrane potential, and proton gradients required for ALP activation. By directly modulating these channels — the control nodes capable of reactivating and rejuvenating the aging ALP — we address the upstream biology driving neurodegeneration rather than chasing downstream consequences.

Our Pipeline: Synergistic Programs To Address Multiple Distinct Lysosomal/Autophagy Deficiencies

Our Pipeline: Synergistic Programs To Address Multiple Distinct Lysosomal/Autophagy Deficiencies

Leadership Team

Our management team has tremendous relevant experience and expertise in lysosomal biology, drug discovery and development.
Yongchang Qiu
President and CEO
Xiang Yang Yu
SVP, Drug Development
Valerie Cullen, PhD
SVP, Head of Research and Translational Sciences
Dr. Junsheng Yang
Senior Director,
Discovery Research

HLC

3E Bioventures

Oceanpine

Board of Directors

Christoph M. Adams, PhD
Independent Board Member
Frank Yan, PhD
Member, 3E Bioventures
Adam Sun, MBA
Board Observer, Oceanpine Capital
Tina Xu, PhD
Member, Highlight Capital
Yongchang Qiu, PhD
Chair, Founder